Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk
Author:
Affiliation:
1. Cardiology Department, University Hospital Ramón Y Cajal. Alcalá University, Madrid, Spain
2. Cardiology Department, University Hospital La Paz, Madrid, Spain
Funder
Viatris Spain
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1925539
Reference91 articles.
1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
3. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
4. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
5. The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk;Journal of Clinical Medicine;2024-03-25
2. Statins;BMJ;2024-01-24
3. Surface modification of polyetherimide/polyvinylpyrrolidone membranes via covalent grafting of heparin: in vitro evaluation of hemocompatibility;Brazilian Journal of Chemical Engineering;2023-12-11
4. STRUGGLE FOR. Włosko-polsko-hiszpańsko-uzbecko-wietnamskie Stanowisko Ekspertów 2023 dotyczące lepszej kontroli klasycznych modyfikowalnych czynników ryzyka w praktyce klinicznej;Choroby Serca i Naczyń;2023-12-05
5. Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum;Journal of the American Heart Association;2023-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3